Science Explorer Interactive view Map
Topic · Immunology

Galectins and Cancer Biology

Galectins and Cancer Biology is a research topic within Immunology. Science Explorer counts 24k research works in it since 1950. 20.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the diverse roles of galectins in immune regulation, inflammation, cancer, macrophage activation, T cell dysfunction, fibrosis, angiogenesis, heart failure, and autoimmunity. Galectins are implicated in modulating various aspects of immune responses and have potential implications for therapeutic interventions in a range of diseases.

  • Galectins
  • Immune Regulation
  • Inflammation
  • Cancer
  • Macrophage Activation
  • T Cell Dysfunction
  • Fibrosis
  • Angiogenesis
  • Heart Failure
  • Autoimmunity
Research works
24k
fractional, since 1950
In the world top 10%
4.8k
per year above
Top-10% rate
20.2%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+6%
the tick is no change

Which countries lead Galectins and Cancer Biology research?

By volume, China and the United States publish the most (1.1k and 584 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 1.1k works
  2. 2 United States 584 works
  3. 3 Japan 178 works
  4. 4 Germany 120 works
  5. 5 India 107 works
  6. 6 Italy 94 works
  7. 7 France 84 works
  8. 8 United Kingdom 80 works
  9. 9 South Korea 70 works
  10. 10 Türkiye 67 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 44.1%United States: 23.6%Japan: 7.2%Germany: 4.9%6 others listed: 20.3%44%largest
China1,093 · 44.1%United States584 · 23.6%Japan178 · 7.2%Germany120 · 4.9%6 others listed503 · 20.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Galectins and Cancer Biology research?

By volume in 2022–2025, Sun Yat-sen University publishes the most Galectins and Cancer Biology research, followed by Nanjing Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022–2025

  1. 1 Sun Yat-sen UniversityChina 16 works
  2. 2 Nanjing Medical UniversityChina 16 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 16 works
  4. 4 Peking UniversityChina 12 works
  5. 5 Shanghai Jiao Tong UniversityChina 12 works
  6. 6 Central South UniversityChina 12 works
  7. 7 Fudan UniversityChina 12 works
  8. 8 Harvard UniversityUnited States 12 works
  9. 9 Huazhong University of Science and TechnologyChina 11 works
  10. 10 InsermFrance 10 works

Where is Galectins and Cancer Biology research done?

The largest centres of Galectins and Cancer Biology research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China).

Largest cities, 2022–2025

  1. 1 Beijing China 124 works
  2. 2 Shanghai China 92 works
  3. 3 Guangzhou China 70 works
  4. 4 Nanjing China 52 works
  5. 5 Wuhan China 46 works
  6. 6 Hangzhou China 43 works
  7. 7 Tokyo Japan 42 works
  8. 8 Paris France 38 works
  9. 9 Moscow Russia 33 works
  10. 10 Chengdu China 31 works
See Galectins and Cancer Biology on the map

Where is the best place to study Galectins and Cancer Biology?

Among universities, judged by research, Nanchang University, Nanjing Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 26.9%fractional works in this node (log) →share in the world top 10% →Nanchang University: 9, 44.4%Nanjing Medical University: 16, 15.8%Chinese Academy of Medical Sciences & Peking Union Medical College: 16, 25.2%Sun Yat-sen University: 16, 34.3%Dalian Medical University: 9, 15.3%Harvard University: 12, 31.0%Fudan University: 12, 25.1%Sichuan University: 10, 33.3%Lund University: 9, 17.5%Central South University: 12, 27.1%Nanchang UniversitySun Yat-sen UniversityChinese Academy of M…Nanjing Medical Univ…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Nanchang UniversityChina 61.544.4%5.7×9 +76.5%
2 Nanjing Medical UniversityChina 58.115.8%9.5×16 +14.9%
3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 53.925.2%4.9×16 +27.3%
4 Sun Yat-sen UniversityChina 53.134.3%3.1×16 -5.6%
5 Dalian Medical UniversityChina 49.615.3%13.9×9 +71.2%
6 Harvard UniversityUnited States 42.531.0%2.8×12 -23.3%
7 Fudan UniversityChina 40.625.1%3.2×12 +16.3%
8 Sichuan UniversityChina 39.633.3%1.8×10 +39.4%
9 Lund UniversitySweden 38.117.5%4.7×9 +25.5%
10 Central South UniversityChina 37.727.1%2.2×12 +9.9%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Galectins and Cancer Biology research growing?

Output in 2018–2022 was 6% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Galectins and Cancer Biology.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.